Blake Moret
Analyst · Barclays
Thanks, Jessica, and good morning everyone. Thank you for joining us on the call today. Please turn to page 3 of the slide deck. I’ll begin by saying that I’m pleased with our execution in the quarter and our start to the year. Despite a tough manufacturing environment, both revenue and earnings were slightly better than our expectations for Q1. Total sales grew 3%, including over 4 points of contribution from inorganic investments primarily related to our Sensia joint venture. Organic sales were down 1% compared to a strong quarter a year ago. Backlog, however, was up year-over-year as well as sequentially. Organic sales performance continues to include market share gains in core platforms. For instance, Independent Cart Motion Control Technology grew strong double-digits for us in the quarter. It is becoming a game-changing solution across a broad range of industries and applications. Information Solutions and Connected Services, or IS/CS for short, had another great quarter, also growing strong double-digits. We had notable wins in Life Sciences, Food & Beverage, our first MES win in Luxury Goods, a significant MES win in Mining, and our first-ever augmented reality project in Oil & Gas. Our broader and more differentiated portfolio gives us more ways to win in a wide variety of industries, including those where we are not the incumbent control platform. Recurring revenue in the quarter grew double digits, led by an increase in software subscriptions. As I mentioned, our earnings performance was slightly better than expected. Segment margins and adjusted EPS include one-time items related to Sensia as well as investments we are making to increase our long-term differentiation. As we look ahead to the rest of the year, we are reaffirming our organic sales and adjusted EPS guidance for fiscal 2020. While there have been recent positive developments on global trade, and the macro environment is showing signs of stabilization, it is still too early to see that impact on customer spending. Let’s now turn to slide 4 and go a little deeper into our vertical sales performance for the quarter. Discrete and Hybrid end-market segments did a little better than we expected this quarter while Process was a little weaker than we expected. Within our Discrete segment, Auto grew mid-single digits, largely related to higher program spend in North America and Asia Pacific, and stabilization in MRO, albeit at low levels. While this higher program spend was better than anticipated, the overall auto market is still relatively weak and we think it is premature to change our flat full year outlook for this vertical. Semiconductor sales were notably better in all regions, up high-single digits. Historically, our exposure to semis has been largely in facilities management, but we are also seeing new traction in material handling, IOT and cybersecurity applications. Turning now to our Hybrid market segment. Food & Beverage declined low-single digits, reflecting some project delays. However, given what we are hearing from customers, and the activity we have seen at packaging OEMs, we still believe Food & Beverage will grow low-single-digits for the year. In Life Sciences, we had another solid quarter, with sales growing both year over year as well as sequentially. As we’ve said before, this is an industry where our scalable architecture and our differentiation in IS/CS are well aligned and paying dividends. Our Process market segment declined slightly, especially in Chemicals and Pulp & Paper. Organically, oil & gas grew mid-single-digits this quarter and we continue to expect low-single-digits sales performance for the year. Sensia, which had a good start to the year, is expected to grow double digits based on its differentiation in the fast-growing, digital oilfield segment of this vertical. Turning to Slide 5 and our regional sales performance in the quarter. North America was down 3% organically, reflecting a weak manufacturing environment. The weakness in process industries was partially offset by Auto, up double-digits, and strength in Semiconductor. EMEA was up 2% in the quarter, led by Oil & Gas, Life Sciences, and Tire. Asia Pacific grew by 6%, led by strong demand for Oil & Gas, Life Sciences, and Auto. Auto was up over 10% in the region and included strong gains at EV battery manufacturers where our readiness to serve is high. Our portfolio is demonstrating how well-positioned we are to benefit from the transition to EV. Latin America sales were down 1%, largely due to a tough comparison from last year and weaker performance in Automotive and Mining. I’ll now make a few additional comments on our other accomplishments in the quarter. Our Annual Automation Fair was held last November in Chicago, and I’m proud to say that we reached a new all-time attendance record. Customers are focusing on outcomes, and sharply increased sales leads from the event indicate we are demonstrating our increased value for a wide variety of industries. We also had record attendance at our Investor Day in November. There, we highlighted our execution plans to accelerate profitable long-term growth, while at the same time build even greater resiliency in our business through higher recurring revenue streams and a leaner more flexible cost structure. We also had record attendance at our Investor Day in November. There we highlighted our execution plans to accelerate profitable long-term growth, while at the same time build even greater resiliency in our business through higher recurring revenue streams and a leaner, more flexible cost structure. We also had exciting new partners at the event, including Schlumberger, Accenture, and Ansys, which is a game-changing technology partner for simulation and digital twin applications. We are seeing our partnerships contribute to many strategic wins and we had some great wins this quarter, including in Life Sciences across all major geographies. In Europe, we signed a major agreement with Roche. Roche will be implementing our PharmaSuite MES platform across 16 plants in their Pharma and Diagnostics divisions. In Europe, we signed a major agreement with Roche. Roche will be implementing our pharma suite MES platform across 16 plants in their Pharma and Diagnostics divisions. In North America, we entered into a new multi-site, multi-year agreement with a major pharmaceutical producer. They selected FactoryTalk Innovation Suite to drive their Digital Transformation program for a connected plant and supply chain. It will provide a common platform to drive real-time visibility of analytics to the operator, plant and enterprise levels, predict future events to avoid unplanned downtime and improve energy efficiency, and accelerate knowledge transfer and improve ease of use. Once implemented, this solution will eliminate hundreds of overlapping edge solutions, resulting in significant operational savings. In China, Ruiying Pharma Group, a large pharmaceutical company, chose Rockwell to transform their factories to become smarter and more predictive, while at the same time assisting them to oversee quality management and ensuring that they comply with regulatory requirements. From regulatory compliance, to safety and energy efficiency, Rockwell is becoming an increasingly important partner of our customers’ ESG initiatives. In addition to what we are doing in our own facilities, everything we do for customers is about increasing efficiency, reducing energy usage, improving worker safety, and ensuring regulatory compliance, all of which lowers business risk and is good for the environment. Now, turning to slide 6, let’s talk a little more about our inorganic investments which are becoming an increasingly important complement to our long-term organic growth strategy. Starting with Sensia, this was our first quarter including Sensia as a fully operational joint venture consolidated in our results, and I am very pleased with its performance in Q1. Operationally, Sensia’s top line grew double digits with strong traction at marquis Oil & Gas customers around the world. Our sales teams have been fully integrated, and we are looking forward to the launch of new solutions and products that will contribute to the double-digit sales performance we expect this year. We also announced the acquisition of MESTECH at the beginning of Q1. MESTECH is an industrial software consulting and delivery services company based in India, and they have already been instrumental in winning key business for us in the quarter. Earlier this month, we announced the acquisition of Avnet Data Security, a cybersecurity provider based in Israel with over 20 years of experience. Cybersecurity is one of the fastest growing parts of our services business. The extensive knowledge and experience of the Avnet team will support our company's strategic objective to achieve double-digit growth in Information Solutions and Connected Services by expanding our IT/OT cyber and network expertise globally. Plus, this acquisition will establish a global cybersecurity Center of Excellence for us in EMEA. This includes a remote managed service center and expands our portfolio of capabilities including a full training curriculum and labs. As you can see, we are actively deploying capital to advance our strategic priorities to accelerate share gains in our core business, continue growing double digits in IS/CS, grow domain expertise in process, and accelerate our market access in Europe and Asia. We are focused on driving value with more intensity than ever before. Let me now turn it over to Patrick who will elaborate on our first quarter financial performance and fiscal 2020 outlook in his remarks. Patrick?